0001666071-20-000242.txt : 20200813 0001666071-20-000242.hdr.sgml : 20200813 20200813191522 ACCESSION NUMBER: 0001666071-20-000242 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200811 FILED AS OF DATE: 20200813 DATE AS OF CHANGE: 20200813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Evans David Thomas CENTRAL INDEX KEY: 0001730451 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 201100782 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wf-form4_159736050594990.xml FORM 4 X0306 4 2020-08-11 0 0001666071 Cardlytics, Inc. CDLX 0001730451 Evans David Thomas C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 0 1 0 0 Chief Administrative Officer Common Stock 2020-08-11 4 M 0 208 0 A 12987 D Common Stock 2020-08-11 4 M 0 741 20 A 13728 D Common Stock 2020-08-11 4 M 0 700 30.44 A 14428 D Common Stock 2020-08-11 4 M 0 700 20 A 15128 D Common Stock 2020-08-11 4 S 0 13019 75.55 D 2109 D Common Stock 2020-08-11 4 S 0 401 76.05 D 1708 D Common Stock 2020-08-12 4 M 0 5509 20 A 7217 D Common Stock 2020-08-12 4 M 0 4769 30.44 A 11986 D Common Stock 2020-08-12 4 M 0 4769 20 A 16755 D Common Stock 2020-08-12 4 S 0 15047 77.14 D 1708 D Common Stock 2020-08-13 4 S 0 86 79.62 D 1622 D Restricted Stock Units 2020-08-11 4 A 0 208 0 A Common Stock 208.0 208 D Restricted Stock Units 2020-08-11 4 M 0 208 0 D Common Stock 208.0 0 D Employee Stock Option (Right to Buy) 20.0 2020-08-11 4 M 0 741 0 D 2026-08-02 Common Stock 741.0 5509 D Employee Stock Option (Right to Buy) 30.44 2020-08-11 4 M 0 700 0 D 2027-07-07 Common Stock 700.0 11019 D Employee Stock Option (Right to Buy) 20.0 2020-08-11 4 M 0 700 0 D 2026-12-06 Common Stock 700.0 7894 D Employee Stock Option (Right to Buy) 20.0 2020-08-12 4 M 0 5509 0 D 2026-08-02 Common Stock 5509.0 0 D Employee Stock Option (Right to Buy) 30.44 2020-08-12 4 M 0 4769 0 D 2027-07-07 Common Stock 4769.0 6250 D Employee Stock Option (Right to Buy) 20.0 2020-08-12 4 M 0 4769 0 D 2026-12-06 Common Stock 4769.0 3125 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $76.01 to $76.09, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $76.64 to $77.58, inclusive. Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on August 11, 2020. Fully vested. This option becomes exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The options becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. /s/ Kirk Somers, Attorney-in-Fact 2020-08-13